VALUE OF SOF/VEL AS PANGENOTYPIC PANFIBROTIC HCV TREATMENT IN IMPLEMENTING A TEST AND TREAT STRATEGY IN PRISONS: REAL-WORLD CARE MANAGEMENT FROM 6 COUNTRIES